Showing results (271-280 of 349) with videos related to
Sort By:
Pageof 35
American Journal of Clinical Oncology|March 31, 2016
Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation TherapyIn J Park, Y Nancy You, John M Skibber, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapyValerie K Reed, Sunil Krishnan, Paul F Mansfield, et al.Cancer Immunology Research|September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?Chad Tang, Xiaohong Wang, Hendrick Soh, et al.Frontiers in Cardiovascular Medicine|March 30, 2018
Ionizing Radiation Induces Endothelial Inflammation and Apoptosis via p90RSK-Mediated ERK5 S496 PhosphorylationHang Thi Vu, Sivareddy Kotla, Kyung Ae Ko, et al.American Journal of Clinical Oncology|October 19, 2016
Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive ChemoradiationEleanor M Osborne, Cathy Eng, John M Skibber, et al.Clinical Colorectal Cancer|March 17, 2020
Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal AdenocarcinomaSantiago Avila, George J Chang, N Arvind Dasari, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progressionChristopher H Crane, Gauri R Varadhachary, John S Yordy, et al.Journal of Gastrointestinal Oncology|January 5, 2018
Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinomaEmma B Holliday, Andrew Hunt, Y Nancy You, et al.Rare Tumors|October 3, 2014
The rare cancer network: ongoing studies and future strategyMahmut Ozsahin, René-Olivier Mirimanoff, Juliette Thariat, et al.Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.Pageof 35